nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—LTK—tongue—larynx cancer	0.0293	0.0293	CbGeAlD
Crizotinib—SBK3—thyroid gland—larynx cancer	0.0217	0.0217	CbGeAlD
Crizotinib—LTK—mouth—larynx cancer	0.0197	0.0197	CbGeAlD
Crizotinib—MET—mouth—larynx cancer	0.0179	0.0179	CbGeAlD
Crizotinib—EPHA4—tongue—larynx cancer	0.0161	0.0161	CbGeAlD
Crizotinib—MET—neck—larynx cancer	0.0153	0.0153	CbGeAlD
Crizotinib—PTK2—exocrine gland—larynx cancer	0.0139	0.0139	CbGeAlD
Crizotinib—IKBKE—thyroid gland—larynx cancer	0.0134	0.0134	CbGeAlD
Crizotinib—LIMK2—mouth—larynx cancer	0.0126	0.0126	CbGeAlD
Crizotinib—IGF1R—neck—larynx cancer	0.012	0.012	CbGeAlD
Crizotinib—EPHA4—mouth—larynx cancer	0.0108	0.0108	CbGeAlD
Crizotinib—PTK2—mouth—larynx cancer	0.0104	0.0104	CbGeAlD
Crizotinib—MET—epithelium—larynx cancer	0.0104	0.0104	CbGeAlD
Crizotinib—BMP2K—neck—larynx cancer	0.01	0.01	CbGeAlD
Crizotinib—PTK2—neck—larynx cancer	0.0089	0.0089	CbGeAlD
Crizotinib—TBK1—neck—larynx cancer	0.0089	0.0089	CbGeAlD
Crizotinib—PRKD1—thyroid gland—larynx cancer	0.00874	0.00874	CbGeAlD
Crizotinib—LIMK1—thyroid gland—larynx cancer	0.00862	0.00862	CbGeAlD
Crizotinib—RPS6KB1—neck—larynx cancer	0.00856	0.00856	CbGeAlD
Crizotinib—PRKD3—thyroid gland—larynx cancer	0.0084	0.0084	CbGeAlD
Crizotinib—BMPR1B—epithelium—larynx cancer	0.00832	0.00832	CbGeAlD
Crizotinib—IKBKE—lymph node—larynx cancer	0.00831	0.00831	CbGeAlD
Crizotinib—DSTYK—thyroid gland—larynx cancer	0.0082	0.0082	CbGeAlD
Crizotinib—IGF1R—epithelium—larynx cancer	0.00816	0.00816	CbGeAlD
Crizotinib—DCLK1—trachea—larynx cancer	0.00805	0.00805	CbGeAlD
Crizotinib—CASK—thyroid gland—larynx cancer	0.00801	0.00801	CbGeAlD
Crizotinib—TIE1—epithelium—larynx cancer	0.00794	0.00794	CbGeAlD
Crizotinib—MAPK7—thyroid gland—larynx cancer	0.00776	0.00776	CbGeAlD
Crizotinib—FES—thyroid gland—larynx cancer	0.00768	0.00768	CbGeAlD
Crizotinib—FER—trachea—larynx cancer	0.00751	0.00751	CbGeAlD
Crizotinib—TNK1—trachea—larynx cancer	0.00743	0.00743	CbGeAlD
Crizotinib—MET—thyroid gland—larynx cancer	0.00726	0.00726	CbGeAlD
Crizotinib—CDK7—thyroid gland—larynx cancer	0.00703	0.00703	CbGeAlD
Crizotinib—TAOK2—thyroid gland—larynx cancer	0.00697	0.00697	CbGeAlD
Crizotinib—TESK1—trachea—larynx cancer	0.00679	0.00679	CbGeAlD
Crizotinib—EPHA3—thyroid gland—larynx cancer	0.00672	0.00672	CbGeAlD
Crizotinib—ACVR1B—thyroid gland—larynx cancer	0.00672	0.00672	CbGeAlD
Crizotinib—RIPK2—epithelium—larynx cancer	0.00653	0.00653	CbGeAlD
Crizotinib—LIMK2—trachea—larynx cancer	0.00646	0.00646	CbGeAlD
Crizotinib—NUAK2—trachea—larynx cancer	0.00643	0.00643	CbGeAlD
Crizotinib—JAK3—thyroid gland—larynx cancer	0.00641	0.00641	CbGeAlD
Crizotinib—ACVR1—trachea—larynx cancer	0.00639	0.00639	CbGeAlD
Crizotinib—DCLK1—thyroid gland—larynx cancer	0.00637	0.00637	CbGeAlD
Crizotinib—STK4—thyroid gland—larynx cancer	0.00629	0.00629	CbGeAlD
Crizotinib—PTK2—epithelium—larynx cancer	0.00606	0.00606	CbGeAlD
Crizotinib—NEK9—lymph node—larynx cancer	0.00595	0.00595	CbGeAlD
Crizotinib—FER—thyroid gland—larynx cancer	0.00594	0.00594	CbGeAlD
Crizotinib—TNK1—thyroid gland—larynx cancer	0.00588	0.00588	CbGeAlD
Crizotinib—RPS6KB1—epithelium—larynx cancer	0.00583	0.00583	CbGeAlD
Crizotinib—MAP4K1—thyroid gland—larynx cancer	0.00582	0.00582	CbGeAlD
Crizotinib—BMPR1B—thyroid gland—larynx cancer	0.00582	0.00582	CbGeAlD
Crizotinib—RIPK2—trachea—larynx cancer	0.00577	0.00577	CbGeAlD
Crizotinib—TNK2—thyroid gland—larynx cancer	0.00571	0.00571	CbGeAlD
Crizotinib—IGF1R—thyroid gland—larynx cancer	0.00571	0.00571	CbGeAlD
Crizotinib—MAP4K2—thyroid gland—larynx cancer	0.00563	0.00563	CbGeAlD
Crizotinib—EPHA4—trachea—larynx cancer	0.00558	0.00558	CbGeAlD
Crizotinib—TIE1—thyroid gland—larynx cancer	0.00555	0.00555	CbGeAlD
Crizotinib—STK3—thyroid gland—larynx cancer	0.00555	0.00555	CbGeAlD
Crizotinib—EPHB4—epithelium—larynx cancer	0.00551	0.00551	CbGeAlD
Crizotinib—JAK2—epithelium—larynx cancer	0.00547	0.00547	CbGeAlD
Crizotinib—PRKD1—lymph node—larynx cancer	0.00543	0.00543	CbGeAlD
Crizotinib—AURKA—thyroid gland—larynx cancer	0.00541	0.00541	CbGeAlD
Crizotinib—EPHA2—epithelium—larynx cancer	0.00541	0.00541	CbGeAlD
Crizotinib—TESK1—thyroid gland—larynx cancer	0.00537	0.00537	CbGeAlD
Crizotinib—TBK1—trachea—larynx cancer	0.00536	0.00536	CbGeAlD
Crizotinib—PTK2—trachea—larynx cancer	0.00536	0.00536	CbGeAlD
Crizotinib—LIMK1—lymph node—larynx cancer	0.00535	0.00535	CbGeAlD
Crizotinib—TYK2—trachea—larynx cancer	0.00532	0.00532	CbGeAlD
Crizotinib—TEK—epithelium—larynx cancer	0.00528	0.00528	CbGeAlD
Crizotinib—MERTK—thyroid gland—larynx cancer	0.00522	0.00522	CbGeAlD
Crizotinib—PRKD3—lymph node—larynx cancer	0.00522	0.00522	CbGeAlD
Crizotinib—RPS6KB1—trachea—larynx cancer	0.00515	0.00515	CbGeAlD
Crizotinib—LCK—trachea—larynx cancer	0.00512	0.00512	CbGeAlD
Crizotinib—LIMK2—thyroid gland—larynx cancer	0.00511	0.00511	CbGeAlD
Crizotinib—AXL—trachea—larynx cancer	0.0051	0.0051	CbGeAlD
Crizotinib—DSTYK—lymph node—larynx cancer	0.00509	0.00509	CbGeAlD
Crizotinib—NUAK2—thyroid gland—larynx cancer	0.00509	0.00509	CbGeAlD
Crizotinib—MAP3K12—thyroid gland—larynx cancer	0.00505	0.00505	CbGeAlD
Crizotinib—ACVR1—thyroid gland—larynx cancer	0.00505	0.00505	CbGeAlD
Crizotinib—BLK—lymph node—larynx cancer	0.00503	0.00503	CbGeAlD
Crizotinib—LTK—lymph node—larynx cancer	0.00498	0.00498	CbGeAlD
Crizotinib—CASK—lymph node—larynx cancer	0.00498	0.00498	CbGeAlD
Crizotinib—STK35—thyroid gland—larynx cancer	0.00495	0.00495	CbGeAlD
Crizotinib—SLK—trachea—larynx cancer	0.00491	0.00491	CbGeAlD
Crizotinib—EPHB4—trachea—larynx cancer	0.00488	0.00488	CbGeAlD
Crizotinib—JAK2—trachea—larynx cancer	0.00484	0.00484	CbGeAlD
Crizotinib—ABL2—thyroid gland—larynx cancer	0.00482	0.00482	CbGeAlD
Crizotinib—MAPK7—lymph node—larynx cancer	0.00482	0.00482	CbGeAlD
Crizotinib—TXK—lymph node—larynx cancer	0.00482	0.00482	CbGeAlD
Crizotinib—EPHA2—trachea—larynx cancer	0.00478	0.00478	CbGeAlD
Crizotinib—FES—lymph node—larynx cancer	0.00477	0.00477	CbGeAlD
Crizotinib—BMP2K—thyroid gland—larynx cancer	0.00477	0.00477	CbGeAlD
Crizotinib—SRC—epithelium—larynx cancer	0.00469	0.00469	CbGeAlD
Crizotinib—MAP3K3—trachea—larynx cancer	0.00467	0.00467	CbGeAlD
Crizotinib—MAP4K5—trachea—larynx cancer	0.00467	0.00467	CbGeAlD
Crizotinib—PTK2B—thyroid gland—larynx cancer	0.0046	0.0046	CbGeAlD
Crizotinib—RIPK2—thyroid gland—larynx cancer	0.00456	0.00456	CbGeAlD
Crizotinib—MET—lymph node—larynx cancer	0.00451	0.00451	CbGeAlD
Crizotinib—EPHB6—trachea—larynx cancer	0.00446	0.00446	CbGeAlD
Crizotinib—EPHA4—thyroid gland—larynx cancer	0.00441	0.00441	CbGeAlD
Crizotinib—CDK7—lymph node—larynx cancer	0.00436	0.00436	CbGeAlD
Crizotinib—TAOK2—lymph node—larynx cancer	0.00433	0.00433	CbGeAlD
Crizotinib—MAP3K2—thyroid gland—larynx cancer	0.00433	0.00433	CbGeAlD
Crizotinib—YES1—trachea—larynx cancer	0.00431	0.00431	CbGeAlD
Crizotinib—TAOK3—trachea—larynx cancer	0.00425	0.00425	CbGeAlD
Crizotinib—PTK2—thyroid gland—larynx cancer	0.00424	0.00424	CbGeAlD
Crizotinib—TBK1—thyroid gland—larynx cancer	0.00424	0.00424	CbGeAlD
Crizotinib—TYK2—thyroid gland—larynx cancer	0.00421	0.00421	CbGeAlD
Crizotinib—ACVR1B—lymph node—larynx cancer	0.00417	0.00417	CbGeAlD
Crizotinib—EPHA3—lymph node—larynx cancer	0.00417	0.00417	CbGeAlD
Crizotinib—IRAK1—thyroid gland—larynx cancer	0.00415	0.00415	CbGeAlD
Crizotinib—RPS6KB1—thyroid gland—larynx cancer	0.00408	0.00408	CbGeAlD
Crizotinib—LCK—thyroid gland—larynx cancer	0.00405	0.00405	CbGeAlD
Crizotinib—FGR—thyroid gland—larynx cancer	0.00405	0.00405	CbGeAlD
Crizotinib—AXL—thyroid gland—larynx cancer	0.00404	0.00404	CbGeAlD
Crizotinib—JAK3—lymph node—larynx cancer	0.00398	0.00398	CbGeAlD
Crizotinib—DCLK1—lymph node—larynx cancer	0.00395	0.00395	CbGeAlD
Crizotinib—PLK4—lymph node—larynx cancer	0.00393	0.00393	CbGeAlD
Crizotinib—STK4—lymph node—larynx cancer	0.00391	0.00391	CbGeAlD
Crizotinib—SLK—thyroid gland—larynx cancer	0.00388	0.00388	CbGeAlD
Crizotinib—EPHB4—thyroid gland—larynx cancer	0.00386	0.00386	CbGeAlD
Crizotinib—JAK2—thyroid gland—larynx cancer	0.00383	0.00383	CbGeAlD
Crizotinib—EPHA2—thyroid gland—larynx cancer	0.00378	0.00378	CbGeAlD
Crizotinib—CSF1R—trachea—larynx cancer	0.00372	0.00372	CbGeAlD
Crizotinib—ALK—lymph node—larynx cancer	0.00369	0.00369	CbGeAlD
Crizotinib—FER—lymph node—larynx cancer	0.00369	0.00369	CbGeAlD
Crizotinib—MAP4K5—thyroid gland—larynx cancer	0.00369	0.00369	CbGeAlD
Crizotinib—MAP3K3—thyroid gland—larynx cancer	0.00369	0.00369	CbGeAlD
Crizotinib—TEK—thyroid gland—larynx cancer	0.00369	0.00369	CbGeAlD
Crizotinib—TNK1—lymph node—larynx cancer	0.00365	0.00365	CbGeAlD
Crizotinib—MAP4K1—lymph node—larynx cancer	0.00362	0.00362	CbGeAlD
Crizotinib—BMPR1B—lymph node—larynx cancer	0.00362	0.00362	CbGeAlD
Crizotinib—TNK2—lymph node—larynx cancer	0.00355	0.00355	CbGeAlD
Crizotinib—IGF1R—lymph node—larynx cancer	0.00355	0.00355	CbGeAlD
Crizotinib—EPHB6—thyroid gland—larynx cancer	0.00353	0.00353	CbGeAlD
Crizotinib—MAP4K2—lymph node—larynx cancer	0.0035	0.0035	CbGeAlD
Crizotinib—TIE1—lymph node—larynx cancer	0.00345	0.00345	CbGeAlD
Crizotinib—STK3—lymph node—larynx cancer	0.00345	0.00345	CbGeAlD
Crizotinib—YES1—thyroid gland—larynx cancer	0.00341	0.00341	CbGeAlD
Crizotinib—STK10—thyroid gland—larynx cancer	0.00338	0.00338	CbGeAlD
Crizotinib—TAOK3—thyroid gland—larynx cancer	0.00337	0.00337	CbGeAlD
Crizotinib—AURKA—lymph node—larynx cancer	0.00336	0.00336	CbGeAlD
Crizotinib—TESK1—lymph node—larynx cancer	0.00333	0.00333	CbGeAlD
Crizotinib—SRC—thyroid gland—larynx cancer	0.00328	0.00328	CbGeAlD
Crizotinib—MERTK—lymph node—larynx cancer	0.00324	0.00324	CbGeAlD
Crizotinib—LIMK2—lymph node—larynx cancer	0.00317	0.00317	CbGeAlD
Crizotinib—NUAK2—lymph node—larynx cancer	0.00316	0.00316	CbGeAlD
Crizotinib—MAP3K12—lymph node—larynx cancer	0.00314	0.00314	CbGeAlD
Crizotinib—FLT3—lymph node—larynx cancer	0.00314	0.00314	CbGeAlD
Crizotinib—ACVR1—lymph node—larynx cancer	0.00314	0.00314	CbGeAlD
Crizotinib—STK35—lymph node—larynx cancer	0.00308	0.00308	CbGeAlD
Crizotinib—ABL2—lymph node—larynx cancer	0.003	0.003	CbGeAlD
Crizotinib—BMP2K—lymph node—larynx cancer	0.00296	0.00296	CbGeAlD
Crizotinib—CSF1R—thyroid gland—larynx cancer	0.00294	0.00294	CbGeAlD
Crizotinib—ABL1—trachea—larynx cancer	0.00294	0.00294	CbGeAlD
Crizotinib—PTK2B—lymph node—larynx cancer	0.00286	0.00286	CbGeAlD
Crizotinib—RIPK2—lymph node—larynx cancer	0.00284	0.00284	CbGeAlD
Crizotinib—EPHA4—lymph node—larynx cancer	0.00274	0.00274	CbGeAlD
Crizotinib—MAP3K2—lymph node—larynx cancer	0.00269	0.00269	CbGeAlD
Crizotinib—TBK1—lymph node—larynx cancer	0.00263	0.00263	CbGeAlD
Crizotinib—PTK2—lymph node—larynx cancer	0.00263	0.00263	CbGeAlD
Crizotinib—TYK2—lymph node—larynx cancer	0.00261	0.00261	CbGeAlD
Crizotinib—IRAK1—lymph node—larynx cancer	0.00258	0.00258	CbGeAlD
Crizotinib—RPS6KB1—lymph node—larynx cancer	0.00253	0.00253	CbGeAlD
Crizotinib—LCK—lymph node—larynx cancer	0.00252	0.00252	CbGeAlD
Crizotinib—FGR—lymph node—larynx cancer	0.00252	0.00252	CbGeAlD
Crizotinib—AXL—lymph node—larynx cancer	0.00251	0.00251	CbGeAlD
Crizotinib—SLK—lymph node—larynx cancer	0.00241	0.00241	CbGeAlD
Crizotinib—EPHB4—lymph node—larynx cancer	0.0024	0.0024	CbGeAlD
Crizotinib—JAK2—lymph node—larynx cancer	0.00238	0.00238	CbGeAlD
Crizotinib—EPHA2—lymph node—larynx cancer	0.00235	0.00235	CbGeAlD
Crizotinib—ABL1—thyroid gland—larynx cancer	0.00233	0.00233	CbGeAlD
Crizotinib—MAP4K5—lymph node—larynx cancer	0.00229	0.00229	CbGeAlD
Crizotinib—MAP3K3—lymph node—larynx cancer	0.00229	0.00229	CbGeAlD
Crizotinib—TEK—lymph node—larynx cancer	0.00229	0.00229	CbGeAlD
Crizotinib—EPHB6—lymph node—larynx cancer	0.00219	0.00219	CbGeAlD
Crizotinib—YES1—lymph node—larynx cancer	0.00212	0.00212	CbGeAlD
Crizotinib—STK10—lymph node—larynx cancer	0.0021	0.0021	CbGeAlD
Crizotinib—TAOK3—lymph node—larynx cancer	0.00209	0.00209	CbGeAlD
Crizotinib—SRC—lymph node—larynx cancer	0.00204	0.00204	CbGeAlD
Crizotinib—CSF1R—lymph node—larynx cancer	0.00183	0.00183	CbGeAlD
Crizotinib—ABL1—lymph node—larynx cancer	0.00145	0.00145	CbGeAlD
Crizotinib—ABCB1—epithelium—larynx cancer	0.00103	0.00103	CbGeAlD
Crizotinib—ABCB1—trachea—larynx cancer	0.000915	0.000915	CbGeAlD
Crizotinib—ABCB1—thyroid gland—larynx cancer	0.000724	0.000724	CbGeAlD
Crizotinib—ABCB1—lymph node—larynx cancer	0.00045	0.00045	CbGeAlD
